Try our Advanced Search for more refined results

IN RE: Trasylol Products Liability Litigation

Track this case

Case Number:

1:08-md-01928

See also:

Court:

Florida Southern

Nature of Suit:

Personal Inj. Prod. Liability

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Donald M. Middlebrooks

Firms

Companies

Sectors & Industries:

Healthcare
- Major
- Medical Appliances & Equipment

April 03, 2013
Bayer Beats Failure-To-Warn Action In Trasylol MDL

A Florida federal judge on Tuesday pared multidistrict litigation over Bayer Corp.'s blood-clotting drug Trasylol after finding an expert witness had not properly considered all the necessary information in finding that the drug was responsible for a heart transplant patient's kidney failure and death.
September 13, 2010
Bayer Wins Toss Of Expert Testimony In Trasylol MDL

Bayer Corp. has persuaded a federal judge to exclude portions of an expert's testimony for plaintiffs in the multidistrict litigation over the company's blood-clotting drug Trasylol.
July 14, 2009
Trasylol Plaintiffs Step Up Fight To See Bayer Report

Plaintiffs in the multidistrict litigation over Bayer AG's Trasylol have intensified efforts to obtain an internal report that allegedly discusses dangers associated with the blood-clotting drug.
April 20, 2009
Trasylol Plaintiffs Fight Bayer For 'Privileged' Docs

Bayer AG is facing calls by plaintiffs in multidistrict litigation over its blood-clotting drug Trasylol to hand over thousands of documents the pharmaceutical company claims are protected by attorney-client privilege.
March 31, 2009
Bayer Wants More Fraud Claims Nixed In Trasylol MDL

Bayer AG has asked a judge to expand his dismissal of fraud claims in three suits to include others in the multidistrict litigation over the blood-clotting drug Trasylol, which Bayer pulled from the market after studies indicating potentially fatal side effects came to light.
August 19, 2008
Bayer Seeks To Toss Fraud Claims From Trasylol MDL

Bayer AG has asked a judge to dismiss fraud claims from a multidistrict lawsuit against the drugmaker over its now-recalled Trasylol, a drug used to reduce blood loss during surgery, saying that the plaintiffs have not pleaded the claim with sufficient particularity.